Sunshine Biopharma (SBFM) Free Cash Flow (2010 - 2026)
Sunshine Biopharma's (SBFM) quarterly Free Cash Flow came in at -$2.1 million in Q1 2026, down 22.01% YoY from -$2.7 million in Q1 2025, and down 28.62% on a QoQ basis from -$1.6 million in Q4 2025.
Sunshine Biopharma (SBFM) Free Cash Flow (2010 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 17 years of Free Cash Flow data on file, last reported at -$2.1 million in Q1 2026.
- Quarterly Free Cash Flow fell 22.01% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.9 million (up 53.46% YoY) and the FY2025 annual result came in at -$5.5 million, up 61.18% from the prior year.
- Free Cash Flow slipped to -$2.1 million in Q1 2026, from -$1.6 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$466923.0 in Q3 2023 to a low of -$5.6 million in Q2 2024.
- A 5-year average of -$2.1 million and a median of -$1.9 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow slumped 681.96% — and 2025, when it jumped 73.84%.
- Tracing SBFM's Free Cash Flow over 5 years: stood at -$2.4 million in 2022, then gained by 5.46% to -$2.3 million in 2023, then tumbled by 52.03% to -$3.5 million in 2024, then jumped by 53.96% to -$1.6 million in 2025, then dropped by 28.62% to -$2.1 million in 2026.
- The last three Free Cash Flow figures came in at -$2.1 million (Q1 2026), -$1.6 million (Q4 2025), and -$735840.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | -924,992.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -924,992.00 |
| Jun 30, 2026 | -924,992.00 |
| Mar 31, 2026 | -2.08 Mn |
| Mar 31, 2026 | -2.08 Mn |
| Dec 31, 2025 | -1.61 Mn |
| Dec 31, 2025 | -1.61 Mn |
| Sep 30, 2025 | -735,840.00 |
| Sep 30, 2025 | -735,840.00 |
| Jun 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | -1.45 Mn |
| Mar 31, 2025 | -1.70 Mn |
| Mar 31, 2025 | -1.70 Mn |
| Dec 31, 2024 | -3.51 Mn |
| Dec 31, 2024 | -3.51 Mn |
| Sep 30, 2024 | -1.87 Mn |
| Sep 30, 2024 | -1.87 Mn |
| Jun 30, 2024 | -5.55 Mn |
| Jun 30, 2024 | -5.55 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Mar 31, 2024 | -3.25 Mn |